Abstract
Laser therapy with semiconductor laser (wavelength 890 nm) was performed in 41 patients with II<SUP>a</SUP> - III<SUP>a</SUP>st. breast cancer. LLLT was used before surgery and in postoperative period during 2 years. LLLT decreased postoperative complications by 15.3% and decreased duration of lymphorrhea. 5 years survival in patients with II<SUP>a</SUP>st. breast cancer treated by LLLT was 100%, in control group--85.71%. In patients with III<SUP>a</SUP>st. breast cancer treated by LLLT survival was 94.44%, in control group--78.94%. 91.3% of patients with II<SUP>a</SUP>st. treated by LLLT had not recurrences in 5 year period, in the controls they were in about 77.7%. 82.35% of patients with III<SUP>a</SUP>st. treated by laser therapy had no recurrences in 5 year period, in control group--60%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
